Full-length YAP had been shown to function as an oncoprotein in rhabdomyosarcomas, undifferentiated pleomorphic sarcomas, and liposarcomas [24] [25] [26]. Here, YAP1 is linked to undifferentiated pleomorphic sarcoma.